Literature DB >> 28271871

Soft tissue sarcomas in adolescents and young adults: a comparison with their paediatric and adult counterparts.

Winette T A van der Graaf1, Daniel Orbach2, Ian R Judson3, Andrea Ferrari4.   

Abstract

Survival outcomes for adolescent and young adult patients with soft tissue sarcomas lag behind those of children diagnosed with histologically similar tumours. To help understand these differences in outcomes, we discuss the following issues with regard to the management of these patients with soft tissue sarcomas: delays in diagnosis, trial availability and participation, aspects of the organisation of care (with an emphasis on age-specific needs), national centralisation of sarcoma care, international consortia, and factors related to tumour biology. Improved understanding of the causes of the survival gap between adolescents and young adults with sarcomas will help drive new initiatives to improve final health outcomes in these populations. In this Review, we specifically focus on embryonal and alveolar rhabdomyosarcoma, synovial sarcoma, and adult soft tissue sarcomas diagnosed in adolescents and young adults, and discuss the age-specific needs of these patients.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Year:  2017        PMID： 28271871     DOI： 10.1016/S1470-2045(17)30099-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


  36 in total

Review 1.  Multimodality imaging of adult rhabdomyosarcoma: the added value of hybrid imaging.

Authors:  Nicolò Gennaro; Andrea Marrari; Salvatore Lorenzo Renne; Ferdinando Carlo Maria Cananzi; Vittorio Lorenzo Quagliuolo; Lucia Di Brina; Marta Scorsetti; Giovanna Pepe; Arturo Chiti; Armando Santoro; Luca Balzarini; Letterio Salvatore Politi; Alexia Francesca Bertuzzi
Journal:  Br J Radiol       Date:  2020-06-26       Impact factor: 3.039

2.  Central nervous system metastasis from osteosarcoma: Case report and literature review.

Authors:  María Tereza Nieto-Coronel; Allan David López-Vásquez; Diana Marroquín-Flores; Sandy Ruiz-Cruz; Jorge Luis Martínez-Tláhuel; Jaime De la Garza-Salazar
Journal:  Rep Pract Oncol Radiother       Date:  2018-07-26

3.  Reactive Oxygen Species (ROS)-Inducing Triterpenoid Inhibits Rhabdomyosarcoma Cell and Tumor Growth through Targeting Sp Transcription Factors.

Authors:  Ravi Kasiappan; Indira Jutooru; Kumaravel Mohankumar; Keshav Karki; Alexandra Lacey; Stephen Safe
Journal:  Mol Cancer Res       Date:  2019-01-04       Impact factor: 5.852

Review 4.  Soft-tissue sarcoma in adolescents and young adults.

Authors:  Toshiyuki Kunisada; Eiji Nakata; Tomohiro Fujiwara; Ako Hosono; Shota Takihira; Hiroya Kondo; Toshifumi Ozaki
Journal:  Int J Clin Oncol       Date:  2022-01-27       Impact factor: 3.402

5.  Changes in Neutrophil-to-lymphocyte Ratio Predict Efficacy of Trabectedin for Soft-tissue Sarcoma.

Authors:  Yasuyoshi Sato; Kenji Nakano; Kuniki Kawaguchi; Naoki Fukuda; Xiaofei Wang; Tetsuya Urasaki; Akihiro Ohmoto; Naomi Hayashi; Mayu Yunokawa; Makiko Ono; Junichi Tomomatsu; Keiko Hayakawa; Yuki Funauchi; Taisuke Tanizawa; Keisuke Ae; Seiichi Matsumoto; Shunji Takahashi
Journal:  Cancer Diagn Progn       Date:  2021-07-03

6.  Prognostic factors of the synovial sarcoma of the extremities: imaging does matter.

Authors:  Mickael Tordjman; Charles Honoré; Amandine Crombé; Amine Bouhamama; Antoine Feydy; Laurent Dercle; Leila Haddag; Pierre-Alban Bouché; Carine Ngo; Axel Le Cesne; Jean-Yves Blay; Olivier Mir; Mehdi Brahmi; Charlotte Martin; Marie Karanian; Samy Ammari; Michele Kind; Virginie Audard; François Le Loarer; Behnam Rabiee; Antoine Italiano; Pascaline Boudou-Rouquette; David Biau; Corinne Balleyguier; Frederique Larousserie; Jean-Luc Drapé; Fadila Mihoubi
Journal:  Eur Radiol       Date:  2022-08-18       Impact factor: 7.034

7.  Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.

Authors:  Mrinal M Gounder; Narasimhan P Agaram; Sally E Trabucco; Victoria Robinson; Richard A Ferraro; Sherri Z Millis; Anita Krishnan; Jessica Lee; Steven Attia; Wassim Abida; Alexander Drilon; Ping Chi; Sandra P D' Angelo; Mark A Dickson; Mary Lou Keohan; Ciara M Kelly; Mark Agulnik; Sant P Chawla; Edwin Choy; Rashmi Chugh; Christian F Meyer; Parvathi A Myer; Jessica L Moore; Ross A Okimoto; Raphael E Pollock; Vinod Ravi; Arun S Singh; Neeta Somaiah; Andrew J Wagner; John H Healey; Garrett M Frampton; Jeffrey M Venstrom; Jeffrey S Ross; Marc Ladanyi; Samuel Singer; Murray F Brennan; Gary K Schwartz; Alexander J Lazar; David M Thomas; Robert G Maki; William D Tap; Siraj M Ali; Dexter X Jin
Journal:  Nat Commun       Date:  2022-06-15       Impact factor: 17.694

8.  Treatment at Specialized Cancer Centers Is Associated with Improved Survival in Adolescent and Young Adults with Soft Tissue Sarcoma.

Authors:  Elysia Alvarez; Sheri L Spunt; Marcio Malogolowkin; Qian Li; Ted Wun; Ann Brunson; Steven Thorpe; Sara Kreimer; Theresa Keegan
Journal:  J Adolesc Young Adult Oncol       Date:  2021-12-15       Impact factor: 1.757

Review 9.  Systemic therapy in pediatric-type soft-tissue sarcoma.

Authors:  K M Ingley; S Cohen-Gogo; A A Gupta
Journal:  Curr Oncol       Date:  2020-02-01       Impact factor: 3.677

10.  "It's Always Been a Second Class Cancer": An Exploration of the Experiences and Journeys of Bereaved Family Carers of People with Sarcoma.

Authors:  Moira O'Connor; Greta Smith; Ashleigh Pantaleo; Darren Haywood; Rhys Weaver; Georgia Kb Halkett
Journal:  Cancers (Basel)       Date:  2021-05-28       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.